James Basta insider trades

Open-market stock purchases and sales by James Basta, EVP, General Counsel at Intellia Therapeutics, Inc, from SEC Form 4 filings since Nov 4, 2019.

Recent trades

DateStockTradeValue
Mar 2, 2026NTLA Intellia Therapeutics, IncSold$16.7K
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Jan 5, 2026NTLA Intellia Therapeutics, IncSold$95.8K

Companies traded

  • NTLA Intellia Therapeutics, Inc: 8 sales, last Mar 2, 2026
  • KURA Kura Oncology, Inc: other filings, last Jan 26, 2021

Get free alerts when James Basta files a new trade →